Arlanzon Technologies Inc is categorized under Commercial Biotechnical Research in San Jose, CA and active since 2004.
Arlanzon Technologies Inc was established in 2004, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Commercial Biotechnical Research business, which does work in the B2B market, and is classified as a Commercial Biotechnical Research, under code number 541711 by the NAICS.
If you are seeking more information, feel free to contact Maria Alonso-Amigo at the company’s single location by writing to 968 Minnesota Avenue, San Jose, California CA 95125 or by phoning (408) 260-7693. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Arlanzon Technologies Inc |
Contact Person: | Maria Alonso-Amigo |
Address: | 968 Minnesota Avenue, San Jose, California 95125 |
Phone Number: | (408) 260-7693 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2004 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Commercial Biotechnical Research |
SIC Code: | 8731 |
NAICS Code: | 541711 |
Share This Business: |
Arlanzon Technologies Inc was started in 2004 to provide professional Commercial Biotechnical Research under the SIC code 8731 and NAICS code 541711. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Maria Alonso-Amigo for inquiries that concern Arlanzon Technologies Inc by calling the company number (408) 260-7693, as your correspondence is most welcome. Additionally, the physical location of the single location of Arlanzon Technologies Inc can be found at the coordinates 37.305426,-121.89403 as well as the street address 968 Minnesota Avenue in San Jose, California 95125.
For its online presence, you may visit Arlanzon Technologies Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.